Published in J Pineal Res on November 01, 2003
Role of melatonin on diabetes-related metabolic disorders. World J Diabetes (2011) 0.93
Oral fluid based biomarkers in periodontal disease: part 1. Saliva. J Int Oral Health (2014) 0.82
Effect of gingival application of melatonin on alkaline and acid phosphatase, osteopontin and osteocalcin in patients with diabetes and periodontal disease. Med Oral Patol Oral Cir Bucal (2013) 0.78
Potential role of melatonin in prevention and treatment of oral carcinoma. Indian J Dent (2014) 0.78
The Role of Nutrition in Periodontal Health: An Update. Nutrients (2016) 0.78
Non-surgical periodontal therapy influences salivary melatonin levels. Clin Oral Investig (2012) 0.77
Melatonin: a novel indolamine in oral health and disease. Int J Dent (2012) 0.77
Reduction of Melatonin Level in Patients with Type II Diabetes and Periodontal Diseases. J Dent Res Dent Clin Dent Prospects (2014) 0.77
Melatonin and oral cavity. Int J Dent (2012) 0.76
Assessment of oral health in peritoneal dialysis patients with and without diabetes mellitus. Perit Dial Int (2011) 0.76
Salivary Markers for Periodontal and General Diseases. Dis Markers (2016) 0.75
Subcellular distribution of melatonin receptors in human parotid glands. J Anat (2013) 0.75
Melatonin: A Review of Its Potential Functions and Effects on Dental Diseases. Int J Mol Sci (2017) 0.75
Effect of topical application of melatonin to the gingiva on salivary osteoprotegerin, RANKL and melatonin levels in patients with diabetes and periodontal disease. Odontology (2013) 0.75
Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci (2014) 1.31
Melatonin mitigates mitochondrial malfunction. J Pineal Res (2005) 1.27
Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res (2011) 1.18
Melatonin-mitochondria interplay in health and disease. Curr Top Med Chem (2011) 1.06
Dysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiency. Hum Mol Genet (2012) 1.06
Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease. Eur J Haematol (2010) 1.05
Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res (2008) 1.01
Mitochondrial DNA and inflammatory diseases. Hum Genet (2011) 1.01
Melatonin: potential functions in the oral cavity. J Periodontol (2007) 0.97
Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J Pineal Res (2006) 0.97
Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin. Int J Biochem Cell Biol (2005) 0.96
Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res (2007) 0.95
Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol (2002) 0.94
Meta-analytic study of implant survival following sinus augmentation. Med Oral Patol Oral Cir Bucal (2012) 0.93
Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J Oral Pathol Med (2006) 0.93
Long-term melatonin administration protects brain mitochondria from aging. J Pineal Res (2009) 0.92
Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice. FEBS J (2007) 0.92
Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology (2002) 0.92
Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem (2006) 0.91
Local application of melatonin into alveolar sockets of beagle dogs reduces tooth removal-induced oxidative stress. J Periodontol (2007) 0.90
Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice. J Neurosci Res (2009) 0.89
Crestal bone loss evaluation in osseotite expanded platform implants: a 5-year study. Clin Oral Implants Res (2011) 0.89
Calreticulin-melatonin. An unexpected relationship. Eur J Biochem (2003) 0.89
Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J (2003) 0.89
Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mech Ageing Dev (2005) 0.88
Melatonin stimulates osteointegration of dental implants. J Pineal Res (2008) 0.88
Relationship between salivary melatonin and severity of periodontal disease. J Periodontol (2006) 0.88
Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8). Exp Gerontol (2010) 0.88
Effect of a combined treatment with growth hormone and melatonin in the cardiological aging on male SAMP8 mice. J Gerontol A Biol Sci Med Sci (2011) 0.88
Melatonin restores the mitochondrial production of ATP in septic mice. Neuro Endocrinol Lett (2006) 0.86
The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS. J Pineal Res (2013) 0.85
Extractions without eliminating anticoagulant treatment: a literature review. Med Oral Patol Oral Cir Bucal (2011) 0.85
Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol (2008) 0.85
Learning capabilities and CA1-prefrontal synaptic plasticity in a mice model of accelerated senescence. Neurobiol Aging (2011) 0.85
Melatonin role in the mitochondrial function. Front Biosci (2007) 0.85
Melatonin stimulates the growth of new bone around implants in the tibia of rabbits. J Pineal Res (2010) 0.85
Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr Top Med Chem (2002) 0.85
Mitochondrial regulation by melatonin and its metabolites. Adv Exp Med Biol (2003) 0.85
Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol (2006) 0.84
Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy. J Pineal Res (2010) 0.84
Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III). Eur J Med Chem (2008) 0.84
Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine. J Hypertens (2004) 0.84
Influence of surface treatment on osseointegration of dental implants: histological, histomorphometric and radiological analysis in vivo. Clin Oral Investig (2014) 0.83
Evaluation of primary stability of self-tapping and non-self-tapping dental implants. A 12-week clinical study. Clin Implant Dent Relat Res (2011) 0.83
Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. J Pineal Res (2007) 0.83
Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis. J Pineal Res (2014) 0.82
Actions of melatonin mixed with collagenized porcine bone versus porcine bone only on osteointegration of dental implants. J Pineal Res (2010) 0.82
Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model. Mech Ageing Dev (2011) 0.82
Agomelatine in depressive disorders: its novel mechanisms of action. J Neuropsychiatry Clin Neurosci (2012) 0.82
The role of mitochondria in brain aging and the effects of melatonin. Curr Neuropharmacol (2010) 0.81
Topical application of melatonin and growth hormone accelerates bone healing around dental implants in dogs. Clin Implant Dent Relat Res (2009) 0.81
Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging. J Pineal Res (2010) 0.81
Oxidative damage in the livers of senescence-accelerated mice: a gender-related response. Can J Physiol Pharmacol (2006) 0.81
Atraumatic maxillary sinus elevation using threaded bone dilators for immediate implants. A three-year clinical study. Med Oral Patol Oral Cir Bucal (2010) 0.81
Evaluation of effects of topic melatonin on implant surface at 5 and 8 weeks in Beagle dogs. Clin Implant Dent Relat Res (2009) 0.81
Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: effects of melatonin treatment. Exp Gerontol (2006) 0.81
4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships. J Med Chem (2004) 0.81
Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice. Free Radic Res (2007) 0.81
Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse. Neurobiol Aging (2011) 0.81
Crestal bone reactions to immediate implants placed at different levels in relation to crestal bone. A pilot study in Foxhound dogs. Clin Oral Implants Res (2013) 0.81
Antioxidant defence and inflammatory response in professional road cyclists during a 4-day competition. J Sports Sci (2010) 0.81
Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis. Endocrine (2005) 0.81
Analysis of the daily changes of melatonin receptors in the rat liver. J Pineal Res (2012) 0.80
Melatonin plus porcine bone on discrete calcium deposit implant surface stimulates osteointegration in dental implants. J Pineal Res (2009) 0.80
Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin. J Pineal Res (2005) 0.79
A review of the melatonin functions in zebrafish physiology. J Pineal Res (2014) 0.79
Melatonin reduces oxidative stress in erythrocytes and plasma of senescence-accelerated mice. J Pineal Res (2006) 0.79
Experimental model of bone response to collagenized xenografts of porcine origin (OsteoBiol® mp3): a radiological and histomorphometric study. Clin Implant Dent Relat Res (2011) 0.79
Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion. Neurobiol Aging (2003) 0.78
Kynurenamines as neural nitric oxide synthase inhibitors. J Med Chem (2005) 0.78